Fulcrum Therapeutics, Inc. (FULC) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Fulcrum Therapeutics, Inc.
02 mai 2023 17h59 HE
|
Robbins LLP
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc....